COST COMPARISON OF ANDEXANET VERSUS PCC FOR DIRECT FACTOR XA INHIBITOR REVERSAL AFTER HEMORRHAGE

被引：0
|
作者：
Frontera, Jennier [1 ]
Joset, Danielle
Lalchan, Rebecca [1 ]
Ahuja, Tania [2 ]
Papadopoulis, John [3 ]
机构：
[1] NYU, Brooklyn, NY USA
[2] NYULMC, New York, NY USA
[3] NYU, New York, NY USA
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
875
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
    Jennifer A. Frontera
    Prachi Bhatt
    Rebecca Lalchan
    Shadi Yaghi
    Tania Ahuja
    John Papadopoulos
    Danielle Joset
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 49 : 121 - 131
  • [2] Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
    Frontera, Jennifer A.
    Bhatt, Prachi
    Lalchan, Rebecca
    Yaghi, Shadi
    Ahuja, Tania
    Papadopoulos, John
    Joset, Danielle
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (01) : 121 - 131
  • [3] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
  • [4] Andexanet Alfa for Factor Xa Inhibitor Reversal
    Wang, Josh J.
    Gosselin, Sophie
    Villeneuve, Eric
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (25): : 2498 - 2498
  • [5] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [6] Concomitant andexanet alfa and 4 F-PCC for Factor Xa inhibitor associated intracranial hemorrhage
    Orban III, James E.
    Ruckel, Cassidy
    Harlan, Sarah
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [7] Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent
    Powell, Jason
    Taylor, James
    Garland, Scott G.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (09) : 940 - 946
  • [8] Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation
    Ghadimi, Kamrouz
    Dombrowski, Keith E.
    Levy, Jerrold H.
    Welsby, Ian J.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (02) : 115 - 122
  • [9] Andexanet Alfa for Factor Xa Inhibitor-Associated Intracerebral Hemorrhage Does a Specific Reversal Agent Justify Its Cost?
    Patel, Nikhil
    Morris, Nicholas A.
    [J]. NEUROLOGY, 2021, 97 (21) : 971 - 972
  • [10] Deterioration free discharge comparison of andexanet-alfa and prothrombin complex concentrates (PCC) for reversal of factor Xa inhibitor associated bleeds
    Keinath, Jason J.
    Lekura, Jona
    Hauser, Christian D.
    Bajwa, Manisha K.
    Bloome, Michael E.
    Kalus, James S.
    Jones, Mathew C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 315 - 322
12345